AWM Investment Company Inc. 13D/13G Filings for OncoCyte Corporation (OCX)

AWM Investment Company Inc. 13D and 13G filings for OncoCyte Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-14
2:41 pm
Purchase
2024-12-3113GOncoCyte Corporation
OCX
AWM Investment Company Inc.1,306,309
7.500%
1,306,309increase
(New Position)
Filing